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Abstract:  Probiotic  bacteria,  mostly  belonging  to  the  genera  Lactobacillus  and 
Bifidobacterium,  confer  a  number  of  health  benefits  to  the  host,  including  vitamin 
production. With the aim to produce folate-enriched fermented products and/or develop 
probiotic  supplements  that  accomplish  folate  biosynthesis  in  vivo  within  the  colon, 
bifidobacteria and lactobacilli have been extensively studied for their capability to produce 
this  vitamin.  On  the  basis  of  physiological  studies  and  genome  analysis,  wild-type 
lactobacilli cannot synthesize folate, generally require it for growth, and provide a negative 
contribution  to  folate  levels  in  fermented  dairy  products.  Lactobacillus  plantarum 
constitutes  an  exception  among  lactobacilli,  since  it  is  capable  of  folate  production  in 
presence of para-aminobenzoic acid (pABA) and deserves to be used in animal trials to 
validate  its  ability  to  produce  the  vitamin  in  vivo.  On  the  other  hand,  several  
folate-producing strains have been selected within the genus Bifidobacterium, with a great 
variability in the extent of vitamin released in the medium. Most of them belong to the 
species B. adolescentis and B. pseudocatenulatum, but few folate producing strains are 
found in the other species as well. Rats fed a probiotic formulation of folate-producing 
bifidobacteria  exhibited  increased  plasma  folate  level,  confirming  that  the  vitamin  is 
produced  in  vivo  and  absorbed.  In  a  human  trial,  the  same  supplement  raised  folate 
concentration in feces. The use of folate-producing probiotic strains can be regarded as a 
new  perspective  in  the  specific  use  of  probiotics.  They  could  more  efficiently  confer 
protection  against  inflammation  and  cancer,  both  exerting  the  beneficial  effects  of 
probiotics  and  preventing  the  folate  deficiency  that  is  associated  with  premalignant 
changes in the colonic epithelia. 
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1. Introduction 
The  consumption  of  live  microbial  supplements  with  presumptive  health  benefits  on  human 
physiology,  the  so-called  probiotics,  has  become  a  common  practice.  Probiotic  bacteria  positively 
impact  on  the  immune  system  and  on  the  composition  and  functioning  of  the  gut  microbiota. 
Furthermore,  the  production  of  vitamins  has  been  claimed  among  the  causal  relationships  of  the 
healthy benefits of probiotics. Folates represent an essential nutrition component in the human diet, 
being  involved  in  many  metabolic  pathways.  The  daily  recommended  intake  as  approved  in  the 
European Union is 400 μg/day for adults [1,2]. Efficiency of DNA replication, repair and methylation 
are affected by folate, therefore high amounts of folate are required by fast proliferating cells such as 
leucocytes, erythrocytes and enterocytes [3]. Epidemiological studies indicated that folate deficiency is 
often  associated with  increased risk of breast cancer  and that low folate homeostasis  may  induce 
hypomethylation of DNA, thereby promoting cancer on the proliferating cells of the colorectal mucosa 
that  supports  rapid  and  continuous  renewal  of  the  epithelium  [4,5].  Furthermore,  increased  folate 
intake is recommended also for patients with inflammatory bowel diseases, contributing to regulation 
of rectal cell turnover [6].  
2. The Intestinal Microbiota and Vitamins 
The human colon harbors a complex and dense microbial population, with up to 10
11 microorganisms 
per gram of intestinal content, mostly represented by anaerobic bacteria. This microbiota also includes 
archaea, yeasts, and other eukaryotes. Although more than 50 bacterial phyla have been described, it is 
dominated by Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria [7]. Within these phyla, 
the  number  of  different  bacterial  species  and  strains  is  extremely  high,  accounting  for  several 
thousands of diverse microorganisms. 
The  gut  microbiota  benefits  the  host,  playing  a  pivotal  role  in  nutrient  digestion  and  energy 
recovery. Colonic bacteria produce enzymes that the host lacks, which are involved in breakdown of 
complex molecules, such as plant polysaccharides. The fermentation of the dietary components that 
escape digestion and absorption in the upper intestinal tract, and of endogenous products such as 
mucin,  results  in  production  of  organic  acids  (e.g.,  acetic,  lactic,  propionic,  and  butyric  acids), 
branched chain fatty acids (e.g., isobutyric, isovaleric, and 2-methylbutyric acids), H2, CO2, ammonia, 
amines and several other end-products. These fermentation products affect the gut environment and the 
host  health,  acting  as  energy  sources,  regulators  of  gene  expression  and  cell  differentiation,  and 
anti-inflammatory  agents.  In  fact,  host-microbe  interactions  are  essential  for  the  resistance  to 
pathogenic infections, gut development, and epithelial homeostasis [8,9].  
The gut microbiota has also been recognized as a source of vitamins. They cannot be synthesized by 
mammals and must be obtained via intestinal absorption from exogenous sources, such as the diet and 
the gut microbiota. Germ-free animals need to be supplemented with vitamin K and certain B vitamins. 
In conventionally colonized animals, these vitamins are produced by several intestinal genera, for Nutrients 2011, 3  
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instance Bacteroides and Eubacterium. Furthermore, it is well established that the ruminal microbiota 
is  a  rich  source  of  vitamins  to  the  ruminant  and  that  the  fecal  bacteria  are  a  major  source  for 
coprophagic rodents [10]. Evidence that commensal colonic bacteria are a significant source of a range 
of vitamins to humans has been presented as well [11]. 
The microbiota of the human colon is known to produce vitamin K (menaquinones) and most of the 
water-soluble  vitamins  of  group  B,  including  biotin,  nicotinic  acid,  folates,  riboflavin,  thiamine, 
pyridoxine,  panthotenic  acid,  and  cobalamin  [11].  In  fact,  the  whole  genetic  information  of  the 
microbial community (microbiome) of the human distal gut revealed a variety of COGs (Clustered 
Orthologous Groups) which are involved in the synthesis of several essential vitamins [12]. Unlike 
dietary vitamins, which are mainly absorbed in the proximal part of the small intestine, the uptake of 
microbial  vitamins  predominantly  occurs  in  the  colon  [13].  Colonocytes  appear  to  be  able  to  
absorb biotin, thiamin,  folates, riboflavin, panthotenic acid, and menaquinones, indicating that the  
microbiota-produced vitamins  may contribute to the systemic vitamin levels and especially to the 
homeostasis of the vitamins in the localized epithelial cells [13,14].  
Folates are hydrophilic anionic molecules that do not cross biological membranes by diffusion, but 
specialized membrane transport systems allow folate accumulation into mammalian cells and tissues. 
Absorption  exploits  several  genetically  and  functionally  distinct  transporters,  such  as  the  folate 
receptors, the family of organic anion transporters, a proton-coupled folate transporter, and the reduced 
folate carrier, which is ubiquitously expressed [15]. Each mechanism plays a unique role in mediating 
the  transport  across  epithelia  and  into  systemic  tissues,  and  contributes  to  folate  homeostasis  in  
humans [16]. Even though absorption occurs primarily in the duodenum and upper jejunum, the colon 
represents a major depot of folate and the vitamin produced by the colonic bacteria exceeds dietary 
intake  and  affects  the  folate  status  of  the  host.  It  is  produced  in  large  quantities  by  the  colonic 
microbiota, mainly as monoglutamylated folate, the form that is absorbed at the highest rate [17], 
intestinal bacteria being one source of this vitamin. Many studies assessed the contribution of intestinal 
microbiota to the folate intake of animal hosts [17–20], and it has been demonstrated that the folate 
synthesized by intestinal bacteria can be absorbed and used by the host [18,21–24]. Recently, direct 
evidence of absorption of folate across the colon has been irrefutably provided [25]. The apparent rate 
of absorption in the colon is considerably lower than that in the small intestine. However, in the distal 
portion of the gastrointestinal tract the transit time is longer than in the small intestine, and the supply 
of folates by the colonic microbiota is constant and continuous, whereas their availability in the upper 
tract is discontinuous and mostly affected by food intake. 
3. Probiotics 
Disturbance of the proper balance of intestinal microbiota is involved in several pathologies, such 
as  inflammatory  bowel  diseases,  metabolic  diseases,  cancer,  and  autoimmune  diseases.  Besides, 
specific intestinal bacteria have been claimed as therapeutic or prophylactic against infections and 
several diseases, and are used as probiotics [26]. Probiotics are defined as ―live microbes which, when 
administered  in  adequate  amounts,  confer  a  health  benefit  to  the  host‖  [27].  Another  definition 
recognizes probiotic as ―a preparation of or a product containing viable, defined microorganisms in 
sufficient numbers, which alter the microflora (by implantation or colonization) in a compartment of Nutrients 2011, 3  
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the host and by that exert beneficial health effects to this host‖ [28]. These nonpathogenic organisms 
do not necessarily possess a phylogenetic relation to one another and are best defined functionally 
rather than taxonomically. Probiotic microorganisms have been identified within different phyla of 
bacteria and yeasts, since a variety of strains of bifidobacteria, lactobacilli, enterococci, streptococci, 
propionibacteria,  Bacillus  sp.,  Escherichia  coli,  and  yeasts  have  been  claimed  to  exert  beneficial 
activities on human health [29]. However, the majority of probiotics in use today belong to the genera 
Lactobacillus and Bifidobacterium.  
The function of the probiotic bacteria, which can be added to foods or consumed as pharmaceutical 
products, includes the reduction of potential pathogenic bacteria and/or harmful metabolites in the 
intestine and the normalization of gastrointestinal functions modulating immunological parameters, 
intestinal  permeability  and  bacterial  translocation,  or  providing  bioactive  or  otherwise  regulatory 
metabolites.  Most  health  effects  of  probiotic  microorganisms  are  determined  by  interactions  with 
immunocompetent cells of the intestinal mucosa. Indeed, the gut-associated lymphoid system is the 
largest immunologically competent organ in the body, and maturation and optimal development of the 
immune  system  since  birth  depends  on  the  development  and  composition  of  the  indigenous  
microbiota [29]. While at first, probiotics were consumed to modulate and improve the gut microbiota 
balance, nowadays specific health effects have been established, and they are supplied to alleviate 
chronic intestinal inflammatory diseases, to prevent and treat pathogen-induced diarrhea, or to manage 
autoimmune and atopic diseases [26,30–32]. 
4. Biosynthesis of Folate 
Both  prokaryotic  and  eukaryotic  cells  require  reduced  folate  cofactors  as  acceptor/donor  of  
one-carbon units in a variety of biosynthetic processes, including the formation of methionine, purines, 
and thymine, and in some degradative reactions. While the cellular requirement for folates is universal, 
methods for obtaining them differ among organisms. Animals cannot synthesize folates and assimilate 
these  derivatives  with  a  diet  exploiting  active  transport  systems.  Diversely,  plants,  fungi,  certain 
protozoa, and several archaea and bacteria can synthesize folates de novo, likely through the same 
general biosynthetic pathway [33] with some modifications [34–38]. 
The folate molecule contain one pterin moiety, originating from 6-hydroxymethyl-7,8-dihydropterin 
pyrophosphate  (DHPPP),  bound  to  para-aminobenzoic  acid  (pABA,  vitamin  B10).  Thus,  de  novo 
biosynthesis  (Figure  1)  necessitates  both  the  precursors,  DHPPP  and  pABA.  The  latter  can  be 
produced  by  plants  and  bacteria  from  the  pentose  phosphate  pathway.  Erythrose  4-phosphate  and 
phosphoenolpyruvate undergo the shikimate pathway to ultimately lead to chorismate, which serves as 
a branching point toward the biosynthesis of aromatic amino acids and pABA. Chorismate is converted 
via  aminodeoxychorismate  synthase  (EC  2.6.1.85)  into  4-amino-4-deoxychorismate.  Subsequently, 
pyruvate is cleaved by 4-amino-4-deoxychorismate lyase (EC 4.1.3.38) to give pABA, which ultimately 
serves for folate biosynthesis. The biosynthesis of DHPPP proceeds via the conversion of guanosine 
triphosphate (GTP) in four consecutive steps. The first step is catalyzed by GTP cyclohydrolase I 
(EC 3.5.4.16) and involves an extensive transformation of GTP, through Amadori rearrangement, to 
form a pterin ring structure. Following dephosphorylation, the pterin molecule undergoes aldolase and 
pyrophosphokinase reactions, which produce the activated pyrophosphorylated DHPPP.  Nutrients 2011, 3  
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Figure  1.  Pathway  of  de  novo  bacterial  biosynthesis  of  folate.  Abbreviations:  
GTP, guanosine triphosphate; DHPPP, 6-hydroxymethyl-7,8-dihydropterin pyrophosphate; 
pABA,  para-aminobenzoic  acid;  DHP,  7,8-dihydropteroate;  DHF,  dihydrofolate;  
THF, tetrahydrofolate. 
 
Folate biosynthesis continues with the formation of a C–N bond joining DHPPP to pABA. This 
condensation reaction, catalyzed by dihydropteroate synthase (EC 2.5.1.15), yields 7,8-dihydropteroate 
(DHP). DHP is glutamylated by dihydrofolate synthase (EC 6.3.2.12) giving dihydrofolate (DHF). Nutrients 2011, 3  
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Then, it is reduced by DHF reductase (EC 1.5.1.3) to the biologically active cofactor tetrahydrofolate 
(THF) and subjected to the addition of multiple glutamate moieties by folylpolyglutamate synthase  
(EC  6.3.2.17)  to  yield  THF-polyglutamate.  Polyglutamilation  may  take  place  also  before  the 
occurrence  of  the  reduction  step,  being  catalyzed  by  DHF  synthase  or,  in  many  bacteria,  by  a 
bifunctional enzyme which is responsible for both EC 6.3.2.12 and EC 6.3.2.17 activities [38]. 
5. Production of Folate by Lactobacilli  
The  genus  Lactobacillus  includes  almost  two  hundreds  recognized  species  of  low  G  +  C 
gram-positive  eubacteria  within  the  phylum  of  the  Firmicutes  and  the  Clostridium-Bacillus 
subdivision [39]. Despite their wide phylogenetic and functional diversity, lactobacilli are invariably 
anaerobic/microaerophilic, aciduric/acidophilic non-sporulating rods. Lactobacilli are included within 
the functional group of lactic acid bacteria (LAB), being saccharolytic and strictly gaining energy 
through the lactic fermentation of carbohydrates, and can be classified as obligate homo-fermentative 
(giving  mainly  lactic  acid),  obligate  hetero-fermentative  (giving  mainly  lactic  acid,  acetic  acid, 
and CO2), or facultative hetero-fermentative [40]. 
Lactobacilli occur in a variety of habitats, including plant-derived matrices, fermented foods (such 
as dairy products and fermented dough, milk, vegetables, and meats), and diverse niches within the 
body of humans and animals. In particular, several species are endogenous members of the resident 
microbiota  of  the  hindgut.  Many  commensal  lactobacilli  have  been  proven  to  exert  a  number  of 
beneficial health effects and have attracted considerable attention as probiotics, although the molecular 
mechanisms behind these beneficial properties are still under investigation. Besides, lactobacilli of 
food  origin  are  primarily  important  in  the  production  of  fermented  products,  but  are  increasingly 
investigated for the production of healthy functional foods. At present, the strains of Lactobacillus 
with the greatest relevance for the manufacturing of probiotics and functional foods belong to the 
species L. acidophilus, L. casei, L. paracasei, L. plantarum, L. reuteri, and L. salivarius [26,29]. 
Due  to  potentially  relevant  applications,  the  ability  to  produce  folate  has  been  intensively 
investigated  in  many  Lactobacillus  isolates  from  a  variety  of  origins.  Strains  from  the  human 
gastrointestinal tract could find application as folate-producing probiotics, while strains from fermented 
foods could be exploited as microbial starters for manufacturing folate-fortified dairy products with 
improved nutritional value. In this perspective, efforts were accomplished to investigate the vitamin 
requirements of lactobacilli and to determine the effects of their growth on folate levels in diverse 
media [41–45]. Recently, the genome sequence of an increasing number of strains of Lactobacillus and 
LAB has provided a major contribution to the knowledge of folate biosynthesis by these bacteria [38], 
even if the number of genomes sequenced is still limited, compared to the total amount of species. 
The analysis of genome sequences for predictable metabolic pathways using KEGG database [46] 
suggests that the ability to synthesize pABA de novo is absent among all the sequenced members of 
the genus Lactobacillus (Table 1). In fact, the enzymes which are necessary for chorismate conversion 
into pABA are lacking. Moreover, the shikimate pathway for chorismate production is complete only 
in the strains of L. plantarum, while it is absent or partial in all the other lactobacilli. Thus, it is 
expected that lactobacilli are generally unable to produce folate in the absence of pABA. Diversely, 
pABA supplementation should be unnecessary in the phylogenetically related genera Lactococcus and Nutrients 2011, 3  
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Streptococcus [40], since all the sequenced lactococci and streptococci, with rare exceptions, possess 
all the genes for both shikimate pathway and chorismate conversion into pABA. 
Table  1.  Genes  and  enzymes  for  the  biosynthesis  of  DHPPP,  THF-polyglutamate, 
chorismate,  and  pABA  predicted  from  the  sequenced  genomes  of  genus  Lactobacillus  
and  other  lactic  acid  bacteria  [46].  Abbreviations:  pABA,  para-aminobenzoic  acid;  
DHPPP, 6-hydroxymethyl-7,8-dihydropterin pyrophosphate; THF, tetrahydrofolate. 
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Lactococcus lactis sbp. cremoris MG1363  f                         
a        
a         
Streptococcus thermophilus CNRZ1066  f                                        
Lactobacillus acidophilus NCFM  f                                         
Lactobacillus brevis ATCC 367  v                                         
Lactobacillus casei ATCC 334  f                                         
Lactobacillus casei BL23  p                                         
Lactobacillus casei Zhang  f                                         
Lactobacillus crispatus ST1  a                                         
Lactobacillus delbrueckii ATCC 11842  f                         
a        
a         
Lactobacillus delbrueckii ATCC BAA-365  f                         
a        
a          
Lactobacillus fermentum IFO 3956  v                                        
Lactobacillus gasseri ATCC 33323  h                                         
Lactobacillus helveticus DPC 4571  f                         
a        
a         
Lactobacillus johnsonii F I9785  a                                         
Lactobacillus johnsonii NCC 533  h                                         
Lactobacillus plantarum JDM1  p                                        
Lactobacillus plantarum WCFS 1  h                                        
Lactobacillus reuteri DSMZ 20016  h                                        
Lactobacillus reuteri JCM 1112  h                                        
Lactobacillus rhamnosus GG  h                                         
Lactobacillus rhamnosus Lc 705  f                                         
Lactobacillus sakei 23K  f                                        
Lactobacillus salivarius UCC 118  h                                         
a, h: human gastro-intestinal tract; a: animal gastrointestinal tract; p: probiotic; f: fermented food (meat or dairy products); 
v: plant; Within each strain, dots with the same color indicate genes organized within the same gene cluster; empty dots 
indicate genes located elsewhere in the genome; Within each strain, dots with the same letter indicate the same gene 
encoding different enzymatic activities.  
The sequenced strains of L. johnsonii, L. acidophilus, L. salivarius, L. brevis, L. casei, L. gasseri, 
L. rhamnosus, and L. crispatus lack the genes of DHPPP de novo biosynthetic pathway and also the 
gene  encoding  dihydropteroate  synthase  (EC  2.5.1.15),  whereas  they  possess  the  genes  for  DHP 
transformation into DHF, THF, and THF-polyglutamate. Therefore, it is expected that these strains  Nutrients 2011, 3  
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are auxotrophic for folates or DHP, and remain incapable of folate production even in the presence  
of pABA supplementation. 
Like Lactococcus lactis, the sequenced strains L. plantarum, L. sakei, L. delbrueckii, L. reuteri, 
L. helveticus, and L. fermentum harbor a folate biosynthesis cluster that includes the gene encoding 
dihydropteroate synthase (EC 2.5.1.15) and all the genes for the biosynthesis of DHPPP, with the 
exception of alkaline phosphatase (EC 3.1.3.1). In L. lactis, the dephosphorylation of dihydroneopterin 
triphosphate into the monophosphate has been demonstrated to occur through an alternative route and 
to  involve  a  Nudix  pyrophosphohydrolase  (with  provisional  number  EC  3.6.1.-)  [47].  Most  of 
lactobacilli harbor a number of genes encoding putative Nudix enzymes (including mutT genes for 
DNA repair), but only L. sakei, L. helveticus, and L. delbrueckii have a homolog of L. lactis gene 
within the fol cluster. Diversely, in L. fermentum, L. plantarum, and L. reuteri, the fol cluster contains 
the gene of a putative non-Nudix purine NTP pyrophosphatase, which is probably responsible for 
hydrolyzing  dihydroneopterin  triphosphate  in  these  species.  Therefore,  L.  plantarum,  L.  sakei, 
L. delbrueckii, L. reuteri, L. helveticus, and L. fermentum are expected to produce DHPPP and may be 
considered as potential folate producers if they are cultured in the presence of pABA. 
Many authors have investigated the ability of LAB to grow in folate-free media and to produce 
folate. L. casei was among the first folate-auxotrophic bacteria to be discovered [48] and among the 
first organisms whose folate uptake system was biochemically described [49–51]. In L. casei and 
L. salivarius, the latter being another folate-auxotrophic species, the uptake proceeds via an abundant 
high affinity membrane-associated binding protein which facilitates the passage of folate across the 
membrane as an electroneutral complex with cations, with an influx that is half-maximal at folate 
concentrations  in  the  nanomolar  range.  The  uptake  system  of  L.  casei  has  been  cloned  and 
characterized, and has been classified within the new class of prokaryotic transporters based on a 
shared energy-coupling factor (ECF). It is based on an ECF component, shared with the transport 
systems  of  thiamine  and  biotin,  plus  a  folate-specific  binding  protein.  The  specific  component  is 
encoded by the gene folT, which has homologs in most of lactobacilli and in other Firmicutes, where 
the corresponding genes may be included within the fol cluster [52,53]. 
Within the cell, the substrate slowly dissociates from internalized binding sites and is sequentially 
metabolized to coenzyme forms and then to membrane-impermeable folylpolyglutamates [49,54,55]. 
More recently, dozens of strains of LAB have been screened for folate production. Unlike the strains 
of  Lactococcus  lactis  subsp.  cremoris,  Lactococcus  lactis  subsp.  lactis,  and  Streptococcus 
thermophilus, the strains of Lactobacillus are generally unable to produce folate with the exception of 
L.  plantarum  [42,56].  The  strains  of  Lactococcus  lactis  and  Streptococcus  thermophilus  were 
demonstrated to produce folate, to accumulate the vitamin within the cells, and excrete it into the 
medium. The extent of vitamin production, the partitioning between accumulation and excretion, and 
the form in which the vitamin occurred (e.g., the number of glutamate residues, and the association to 
formyl or methenyl groups) mostly depended on the strain and, in some cases, were influenced by 
culture conditions, such as the pH, the growth rate and the presence of pABA. On the contrary, the 
strains of Lactobacillus consumed folate with the exception of L. plantarum. With hindsight, these 
observations are in agreement with the presence or the lack of the genes for folate biosynthesis, as 
predicted from the sequenced genomes. Nutrients 2011, 3  
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Several  attempts  were  carried  out  to  exploit  strains  of  Lactobacillus  for  folate  fortification  of 
fermented dairy products, but the use of just lactobacilli is likely to deplete the folate levels of the 
fermented product [56–61]. Nonetheless, folate production and utilization is additive in mixed cultures 
of S. thermophilus and lactobacilli. Thus, increased folate levels in yoghurt and fermented milk are 
possible  through  judicious  selection  of  inoculum  species,  even  though  the  folate  levels  remain 
relatively low in terms of recommended daily intake [56]. 
Combining  genome-based  metabolic  models  with  growth  experiments  on  minimal  media  is 
fundamental to unravel the authentic metabolic capabilities and nutritional requirements of bacteria 
and to reveal inconsistencies between the predictions and their actual behavior. Specifically, it was 
found that amino acids, bases and nucleosides present in non-minimal media could circumvent the 
need  for  specific  cofactors  such  as  folate  and  pABA  [62,63].  Genome-based  predictions  and  the 
utilization of chemically defined media have been satisfactorily combined only for L. plantarum so 
far [45]. Using a medium lacking all components needed for folate production or folate-dependent 
metabolite formation, it was demonstrated that, in the presence of pABA, L. plantarum produced a 
surplus  of  folate  that  exceeded  the  requirement  of  its  own  metabolism.  The  absence  of  pABA 
suppressed the production, but did not affect growth rate or biomass formation at all, thus the presence 
of an alternative cofactor for the one-carbon donation may not be excluded. 
In silico analysis of the folate biosynthesis genes of the B12 producer L. reuteri JCM1112 was used 
to develop a metabolic engineering strategy and to optimize the composition of pABA-supplemented 
fruit-based media aiming at combining the production of B12 and folate in the desired ratio [43]. The 
overexpression  in  L.  reuteri  of  the  complete  folate  biosynthesis  gene  cluster  from  L.  plantarum 
increased folate production to levels substantially higher than those previously described, even though 
these recombinant strains cannot be directly used by the food industry. 
6. Production of Folate by Bifidobacteria 
Bifidobacterium  is  a  genus  of  high  G  +  C  Gram-positive  eubacteria  within  the  phylum  of 
Actinobacteria. They are saccharolytic obligate anaerobes whose primary habitat is the gastrointestinal 
tract  of  animals,  being  among  the  first  gut  colonizers.  Among  nearly  fifty  species  recognized  so 
far [39],  the  most  represented  in  the  gastrointestinal  tract  of  human  adults  or  infants,  are 
Bifidobacterium pseudocatenulatum, B. catenulatum, B. adolescentis, B. longum, B. infantis, B. breve, 
B. angulatum and B. dentium [64]. Bifidobacteria are one of the most important health-promoting 
groups  of  the  colonic  microbiota  and  one  of  the  most  important  microorganisms  to  be  used  as 
probiotics.  Several  reports  provided  insight  into  metabolic,  trophic  and  protective  functions  that 
reinforce the functional claims of bifidobacteria. They produce lactic and acetic acids which acidify the 
large intestine and restrict putrefactive and potentially pathogenic bacteria, inhibit the attachment and 
the  growth  of  transient  organisms  and  pathogens,  repress  harmful  enzymatic  activities  within  the 
microbiota, activate a number of dietary compounds into bioactive healthy molecules, and produce 
vitamins and amino acids. Furthermore, they have been demonstrated to participate in the regulation of 
intestinal homeostasis, modulate local and systemic immune responses, and play an important role in 
the protection against cancer and inflammatory diseases [29,65]. However, the mechanisms of action Nutrients 2011, 3  
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are not yet completely understood and it is likely that more than one mechanism works simultaneously 
to bring about the health benefits [65]. 
Among intestinal bacteria, bifidobacteria are generally considered to synthesize several B group 
vitamins, including folate, biotin, thiamine, nicotinic acid, pyridoxine, riboflavin, and B12, but have 
not  been  reported  to  produce  vitamin  K.  Nonetheless,  the  capability  of  bifidobacteria  to  produce 
vitamins and to release them extracellularly has never been explored in depth, with the sole exception 
of folate [22,66,67]. In fact, the lack of suitable analytical methods with sufficient sensitivity, and of a 
general synthetic medium where most Bifidobacterium spp. abundantly grow, has delayed an extensive 
screening of Bifidobacterium strains for auxotrophies, synthesis, and secretion of vitamins. 
Based  on  the  analysis  of  genome  sequences  for  predictable  metabolic  pathways  [46],  all  the 
sequenced  bifidobacteria  possess  the  entire  set  of  the  genes  for  the  shikimate  pathway  and  are  
expected  to  produce  chorismate  (Table  2).  Even  though  they  harbor  the  gene  encoding  the 
aminodeoxychorismate synthase (EC 2.6.1.85), only the strains of  B. adolescentis and B. dentium 
possess the 4-amino-4-deoxychorismate lyase (EC 4.1.3.38) and are expected to accomplish de novo 
biosynthesis of pABA. Both the sequenced strains of B. animalis subsp. lactis lack the gene encoding 
dihydropteroate synthase (EC 2.5.1.15) and all the genes for the biosynthesis of DHPPP, thus they 
should behave auxotrophic for folates or DHP, and remain incapable of folate production even in the 
presence of pABA supplementation.  
Table  2.  Genes  and  enzymes  for  the  biosynthesis  of  DHPPP,  THF-polyglutamate, 
chorismate,  and  pABA  predicted  from  the  sequenced  genomes  of  genus 
Bifidobacterium [46].  Abbreviations:  pABA,  para-aminobenzoic  acid;  DHPPP,  
6-hydroxymethyl-7,8-dihydropterin pyrophosphate; THF, tetrahydrofolate. 
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B. adolescentis ATCC 15703  h     
a       
a                     
a   
a         
B. animalis subsp. lactis AD011  h     
a       
a                               
B. animalis subsp. lactis Bl-04  h     
a       
a                               
B. animalis subsp. lactis DSMZ 10140  f     
a       
a                               
B. dentium Bd1  h     
a       
a                     
a   
a         
B. longum DJO10A  h     
a       
a                     
a   
a         
B. longum NCC2705  h     
a       
a                     
a   
a         
B. longum subsp. infantis ATCC 15697  h     
a       
a                     
a   
a         
B. longum subsp. longum JDM301  p     
a       
a                
  
   
a   
a         
a, h: human gastro-intestinal tract; p: probiotic; f: fermented food (meat or dairy products); Within each strain, dots with 
the same color indicate genes organized within the same gene cluster; empty dots indicate genes located elsewhere; 
Within each strain, dots with the same letter indicate the same gene encoding different enzymatic activities. Nutrients 2011, 3  
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All  the  other  sequenced  bifidobacteria  harbor  a  cluster  of  fol  genes  encoding  dihydropteroate 
synthase (EC 2.5.1.15) and some enzymes for the biosynthesis of DHPPP. Therefore, bifidobacteria 
are  expected  to  carry  out  the  condensation  between  pABA  and  DHPPP.  Unlike  lactobacilli,  the 
fol cluster  of  bifidobacteria  encodes  for  neither  pyrophosphohydrolase  (EC  3.6.1.-)  nor  alkaline 
phosphatase  (EC  3.1.3.1).  Several  putative  Nudix  pyrophosphatases  and  alkaline  phosphatase  are 
widespread in all the sequenced genomes of bifidobacteria, but it is not possible to argue whether they 
are involved in folate biosynthesis, because their function has not been investigated so far. Therefore, 
it  should  not  be  excluded  that  B.  adolescentis,  B.  dentium,  and  B.  longum  can  accomplish  the 
dephosphorylation of dihydroneopterin through an enzyme so-far unidentified or an enzyme-independent 
chemical process, and can synthesize DHPPP. Furthermore, it is conceivable that B. adolescentis and 
B. dentium  are  capable of  de  novo folate production,  while B. longum needs to be provided  with 
pABA, and B. animalis requires folate. 
Several strains of bifidobacteria have been screened for their ability to produce folate in low-folate 
or  folate-free  media.  Twenty-four  strains  of  B.  bifidum,  B.  infantis,  B.  breve,  B.  longum,  and 
B. adolescentis  were  cultured  in  a  low-folate  semisynthetic  medium  and  significant  differences  in 
vitamin accumulation were found among the species tested [66]. All B. bifidum and B. infantis strains 
were classified as high folate accumulators, while B. breve, B. longum, and B. adolescentis produced 
lower  amounts  of  the  vitamin.  For  all  the  strains,  extracellular  folate  accounted  for  most  of  the 
accumulated vitamin [68]. In other studies, the highest folate accumulation in reconstituted skim-milk 
was obtained after incubation with B. breve and B. infantis or B. longum strains [69]. 
Rather different results were obtained when 76 wild-type strains were screened in a folate-free 
semisynthetic medium [66]. Supplementation of folate was necessary for the growth of most of the 
strains, and the ability to produce the vitamin in the folate-free medium was found only in 17 strains 
belonging to nine different species (B.  adolescentis, B. breve, B. pseudocatenulatum, B. animalis, 
B. bifidum, B. catenulatum, B. dentium, B. infantis, and B. longum). The vitamin production was not 
related to the extent of the growth, and was not a characteristic of the species, but seemed to be a trait 
of  the  single  strains.  The  vitamin  was  mainly  extracellular;  intracellular  accumulation  was 
strain-dependent and ranged between 9 and 38% of total vitamin production. The highest extracellular 
folate levels (between 41 and 82 ng mL
−1) were produced by four strains of B. adolescentis and two of 
B. pseudocatenulatum. Only one out of 15 B. longum strains grew in folate free-medium. 
The discrepancy with the studies that did not identify B. adolescentis and B. pseudocatenulatum as 
high-producers  may  be  due  to  both  strain-to-strain  differences  and  to  different  experimental  
designs  [66,68].  Unlike  the  previous  studies,  folate-free medium  was  used,  and  the  cultures  were 
passaged  seven  times  in  this  medium  to  exhaust  the  vitamin  before  evaluating  growth  and  folate 
production [66]. Furthermore, it is conceivable that several strains have been phenotypically identified 
and classified when the number of species was lower, and need reclassification based on molecular 
phylogenetic analyses.  
In the perspective to develop a probiotic based on folate-producing strains, it is important that 
vitamin  biosynthesis  is  not  affected  by  the  environmental  conditions  occurring  in  the  colon,  and 
particularly  by  the  level  of  exogenous  vitamin,  whose  concentration  range  can  be  rather  large 
depending on the dietary intake, absorption and excretion from urine, skin and bile [6]. Among the Nutrients 2011, 3  
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above strains, two B. adolescentis and one B. pseudocatenulatum were selected since they did not 
exhibit any feed-back regulation of folate production, due to the presence of exogenous vitamin in the 
range between 0 and 50 ng mL
−1 [66]. Furthermore, neither pH nor the carbon source affected folate 
biosynthesis. These selected strains were administered to Wistar rats with induced folate deficiency, in 
order to investigate their effectiveness to improve folate status [22]. Lyophilized bifidobacteria were 
used  alone  or  were  added  to  bifidogenic  fructans  in  a  synbiotic  formulation.  At  the  end  of  the 
treatment, mean serum folate concentration in rats consuming both the probiotic and synbiotic diet was 
significantly  higher  than  in  controls.  However,  the  simultaneous  consumption  of  probiotics  and 
prebiotic carbohydrates further increased the level of the probiotic strains in the intestine and resulted 
in the highest level of serum folate, confirming that the availability of a preferred indigestible carbon 
source is advantageous for the growth and the metabolic activity of probiotic bacteria.  
These  same  strains  of  B.  adolescentis  and  B.  pseudocatenulatum,  when  given  to  23  healthy 
volunteers  in  a  pilot  human  study,  significantly  increased  folate  concentration  in  the  feces  of  the 
subjects [67]. These results corroborate the assumption that the increase of folate levels was markedly 
due to the effective growth of the folate-producing bifidobacteria. In this case, the levels of commensal 
bifidobacteria  in  the  large  intestine  correlated  with  the  vitamin  availability,  suggesting  that 
bifidobacteria are capable of producing folate in the gut, and that the folate synthesized in the large 
intestine can be absorbed and utilized by the host. In agreement with these results, in folate-depleted 
rats  the  administration  of  diets  containing  bifidogenic  ingredients  (e.g.,  human  milk  solids  or 
prebiotics) increased the folate concentration in the cecum, colon, plasma, and colonic tissue [70,71]. 
These results support evidence that folate-producing probiotic strains may represent an endogenous 
source of vitamin, preventing its deficiency in the colon. Localized folate production in the large 
intestine may provide the proliferating enterocytes with this essential vitamin with potential effects in 
reducing colonic carcinogenesis [72]. Therefore, the trophic effects on colonocytes of folate-producing 
strains deserve to be evaluated. Moreover, the supply of folate by bifidobacteria may also contribute to 
lower  hyperhomocysteinemia,  since  the  administration  of  folate-producing  B.  longum  exerted 
beneficial effects on the homocysteine levels of hemodialysis patients [73]. 
Besides their exploitation as an endogenous source of vitamin, folate-producing bifidobacteria may 
also be used to fortify fermented dairy products, as milk is a poor source of folate. This concept was 
tested in a particular study where seven strains of Bifidobacterium were evaluated for their capacity to 
enhance the folate concentration of reconstituted skim milk, resulting in a strain of B. breve being 
selected as the most promising [56]. Moreover, mixed culture fermentations of reconstituted skim milk 
were successfully carried out using folate-producing strains of Bifidobacterium in conjunction with 
strains  of  Streptococcus  thermophilus  and/or  Lactobacillus  delbrueckii  subsp.  bulgaricus  from 
conventional  yogurt,  demonstrating  that  it  is  possible  to  increase  folate  levels  in  fermented  milk 
products through appropriate selection of bacterial strains. 
7. Conclusions  
The use of folate-producing strains can be regarded as a new perspective on the specific uses of 
probiotics.  Within  the  genus  Lactobacillus,  the  strains  belonging  to  the  species  L.  plantarum  are 
expected to produce folate in the presence of preformed pABA, while the other species cannot be Nutrients 2011, 3  
 
 
130 
regarded as folate producers. Therefore, the application of lactobacilli as folate-producing probiotics 
seems to be precluded, even though selected strains of L. plantarum deserve to be used in animal trials 
to provide evidence of their ability to produce folate in vivo. Unlike lactobacilli, several folate-producing 
Bifidobacterium strains have been selected, but the release of high amounts of vitamin does not seem 
to be widespread within the genus. Animal trials confirmed that the administration of folate-producing 
bifidobacteria positively affected the plasmatic folate level, indicating that the vitamin is produced 
in vivo by the probiotic strains, and absorbed. In a human trial, the administration of the same strains 
resulted in a significant increase of folate concentration in feces. Even though the effect on plasmatic 
levels has not been investigated so far, folate-producing bifidobacteria may provide a complementary 
endogenous source of the vitamin and may contribute to prevent folate deficiency, which is often 
associated with premalignant changes in the colonic epithelia. 
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